SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-057798
Filing Date
2021-11-19
Accepted
2021-11-19 17:13:02
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acer-10q_20210930.htm   iXBRL 10-Q 2169390
2 EX-31.1 acer-ex311_6.htm EX-31.1 17682
3 EX-31.2 acer-ex312_8.htm EX-31.2 17721
4 EX-32.1 acer-ex321_9.htm EX-32.1 7894
5 EX-32.2 acer-ex322_10.htm EX-32.2 7541
6 GRAPHIC gsnvrylta201000001.jpg GRAPHIC 17440
  Complete submission text file 0001564590-21-057798.txt   6867887

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA acer-20210930.xsd EX-101.SCH 53482
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20210930_cal.xml EX-101.CAL 35441
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20210930_def.xml EX-101.DEF 180535
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20210930_lab.xml EX-101.LAB 399704
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20210930_pre.xml EX-101.PRE 312390
12 EXTRACTED XBRL INSTANCE DOCUMENT acer-10q_20210930_htm.xml XML 861286
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 211429277
SIC: 2834 Pharmaceutical Preparations